Trial intelligence / Profile preview

HRS4800 for Postoperative Pain After Impacted Tooth Removal

NCT05318846Phase 2Completed

Sponsor
Hengrui
Start
Jan 2022
Primary completion
Feb 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of HRS-4800 in postoperative pain, sponsored by Hengrui. Started Jan 2022; status: completed.

02

Drugs

HRS-4800
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05318846.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05318846.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call